{"id":741222,"date":"2023-03-20T08:49:24","date_gmt":"2023-03-20T12:49:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/"},"modified":"2023-03-20T08:49:24","modified_gmt":"2023-03-20T12:49:24","slug":"igc-announces-rebranding-changes-name-to-igc-pharma-inc","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/","title":{"rendered":"IGC Announces Rebranding, Changes Name to IGC Pharma, Inc."},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">POTOMAC, Md., March  20, 2023  (GLOBE NEWSWIRE) &#8212; India Globalization Capital, Inc. (NYSE American: IGC) (\u201cIGC\u201d or the \u201cCompany\u201d) today announces it will begin operating under the new name IGC Pharma, Inc., (dba IGC) effective March 30, 2023, as part of a rebranding strategy that better reflects IGC Pharma\u2019s strategic focus and vision for the future.<\/p>\n<p align=\"justify\">Our common stock will continue to be quoted on the NYSE American under the same symbol IGC. Trading of our common stock under our new name will commence on March 31, 2023. Our CUSIP and EIN numbers will remain the same.<\/p>\n<p align=\"justify\">The name change to IGC Pharma, Inc. acknowledges the Company\u2019s identity as a developer of drug assets for treating diseases, including, but not limited to, Alzheimer\u2019s disease. IGC believes it has the first natural, cannabis-based, patent-protected compound that relies on low doses of THC, a psychoactive cannabinoid, and another compound as pharmaceutically active agents (APIs) for the treatment of Alzheimer\u2019s disease. IGC is currently in a Phase 2 trial with its THC-based investigational medication, IGC-AD1, for the treatment of agitation in Alzheimer\u2019s. IGC-AD1 is the only natural, THC-based investigational drug candidate currently undergoing FDA trials on Alzheimer\u2019s (registered on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Bh5gyPH0G_8drPXeq7uyYO8QK5zg1Zz2NRidQM7LwtjShO6Yy7f7Cvn8NE73f6iF4O0JGuVp68aRUMc_Ag9fmlEBzansSrs-GYxxcuxR6Fs=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/clinicaltrials.gov\/<\/a>). The APIs in IGC Pharma\u2019s leading drug asset, IGC-AD1, have shown in preclinical studies on Alzheimer\u2019s cell lines the potential to be effective in ameliorating a key protein responsible for A\u03b2 plaques, a key hallmark of Alzheimer\u2019s. IGC also markets a wellness brand, Holief\u2122,\u00a0that targets women experiencing premenstrual syndrome, menstrual cramps and sleep disorders.<\/p>\n<p align=\"justify\">\u201cOur business has gone through a transformation over the past several years, and changing our name to IGC Pharma, Inc. (dba IGC) represents a major milestone by now clearly aligning our name with our strategic focus as a leading developer and provider of THC-based drug assets,\u201d Ram Mukunda, chief executive officer of IGC, commented. \u201cWe\u2019re encouraged by the performance of our investigational drug candidate, IGC-AD1, in FDA trials on agitation in Alzheimer\u2019s, and our consumer products continue to gain traction in the market. Given our progress, we felt it made sense to rebrand and rename our Company to more accurately reflect our business focus, our research and development progress in the Phase II clinical trial on Alzheimer\u2019s, and our strategic vision.\u201d<\/p>\n<p>\n        <strong><br \/>\n          <u>About IGC<\/u><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <u>Pharma, Inc.<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">IGC Pharma (dba IGC) develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer\u2019s disease, period cramps (\u201cdysmenorrhea\u201d), premenstrual syndrome (\u201cPMS\u201d) and chronic pain. IGC has two investigational drug assets targeting Alzheimer\u2019s disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer\u2019s cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer\u2019s disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol (\u201cTHC\u201d) based formulation that is currently in a 146-person Phase 2 safety and efficacy clinical trial for agitation in dementia due to Alzheimer\u2019s (clinicaltrials.gov, NCT05543681). IGC also markets a wellness brand, Holief\u2122, that targets women experiencing premenstrual syndrome and menstrual cramps. IGC is headquartered in Maryland, USA, and has historically operated an infrastructure segment based in India.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Forward-<\/u><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <u>L<\/u><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <u>ooking Statements<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">This press release contains forward-looking statements. These forward-looking statements are based largely on IGC\u2019s expectations and are subject to several risks and uncertainties, certain of which are beyond IGC\u2019s control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, the Company\u2019s failure or inability to commercialize one or more of the Company\u2019s products or technologies, including the products or formulations described in this release, or failure to obtain regulatory approval for the products or formulations, where required; general economic conditions that are less favorable than expected, including as a result of the ongoing COVID-19 pandemic; the FDA\u2019s general position regarding cannabis- and hemp-based products; and other factors, many of which are discussed in IGC\u2019s U.S. Securities and Exchange Commission (\u201cSEC\u201d) filings. IGC incorporates by reference the human trial disclosures and Risk Factors identified in its Annual Report on Form 10-K, filed with the SEC on June 23, 2022, as if fully incorporated and restated herein. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this release will occur.<\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>IMS Investor Relations<br \/>Walter Frank<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4lSPeYBHy_i5i-c6GTNFAHBYTu0zctUGv7H3P66o48DG6k8qSZgznGhSZfeuu2UXGwbj89IEQcGkwlKwT5pCKV5LcVje1mDuP83QyRyuHP3renZyaCz2EFSzZCyoF5Mg\" rel=\"nofollow noopener\" target=\"_blank\">igc@imsinvestorrelations.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7eTSQQ1itMhn0aHX7CiKcZQ8Ha76TcgpdYhLc9AzIPPiQ3f6aP-aY8V_ozUZtqc2fY1m-6hpUn1YeLRx5nuaOQ==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/><\/a>(203) 972-9200<\/p>\n<p>\n        <strong>Corporate Communications<\/strong><br \/>\n        <br \/>IBN (InvestorBrandNetwork)<br \/>Los Angeles, California<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j-M7OojZFU7p4yM_I6KWw2jFDk_BlJ9GWo7woHo3Hdem_5X2p-Z7I1fOLbRNlOq1x52rJe4IbcHEO0gLPVZdhonEelFwf9K7Qy8fr2nYjYx_YxTiGk5omOmK1yZycJgB\" rel=\"nofollow noopener\" target=\"_blank\">www.InvestorBrandNetwork.com<\/a><br \/>310-299-1717 Office<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RYPnkqHuAjTHGjsR0K0Rg80l1Vdg6bh0cWBXHTJ7p5zK-s_VBPhy4jUqsltqN2VOnzukM_ULFoPNRG0JiOZ-E352EvlRRWopLw8-zRRdgPPHL5S04NLJhQgTPbqIiZ62\" rel=\"nofollow noopener\" target=\"_blank\">Editor@InvestorBrandNetwork.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTEzNSM1NDY5OTEwIzUwMDExMTY0NA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OGM0ZmJlNmMtZWVkMC00YWE3LWE1MzAtMzRlNTM1ZThlOGYyLTUwMDExMTY0NA==\/tiny\/IGC-Pharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>POTOMAC, Md., March 20, 2023 (GLOBE NEWSWIRE) &#8212; India Globalization Capital, Inc. (NYSE American: IGC) (\u201cIGC\u201d or the \u201cCompany\u201d) today announces it will begin operating under the new name IGC Pharma, Inc., (dba IGC) effective March 30, 2023, as part of a rebranding strategy that better reflects IGC Pharma\u2019s strategic focus and vision for the future. Our common stock will continue to be quoted on the NYSE American under the same symbol IGC. Trading of our common stock under our new name will commence on March 31, 2023. Our CUSIP and EIN numbers will remain the same. The name change to IGC Pharma, Inc. acknowledges the Company\u2019s identity as a developer of drug assets for treating diseases, including, but not &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IGC Announces Rebranding, Changes Name to IGC Pharma, Inc.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-741222","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IGC Announces Rebranding, Changes Name to IGC Pharma, Inc. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IGC Announces Rebranding, Changes Name to IGC Pharma, Inc. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"POTOMAC, Md., March 20, 2023 (GLOBE NEWSWIRE) &#8212; India Globalization Capital, Inc. (NYSE American: IGC) (\u201cIGC\u201d or the \u201cCompany\u201d) today announces it will begin operating under the new name IGC Pharma, Inc., (dba IGC) effective March 30, 2023, as part of a rebranding strategy that better reflects IGC Pharma\u2019s strategic focus and vision for the future. Our common stock will continue to be quoted on the NYSE American under the same symbol IGC. Trading of our common stock under our new name will commence on March 31, 2023. Our CUSIP and EIN numbers will remain the same. The name change to IGC Pharma, Inc. acknowledges the Company\u2019s identity as a developer of drug assets for treating diseases, including, but not &hellip; Continue reading &quot;IGC Announces Rebranding, Changes Name to IGC Pharma, Inc.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-20T12:49:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTEzNSM1NDY5OTEwIzUwMDExMTY0NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IGC Announces Rebranding, Changes Name to IGC Pharma, Inc.\",\"datePublished\":\"2023-03-20T12:49:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\\\/\"},\"wordCount\":745,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MTEzNSM1NDY5OTEwIzUwMDExMTY0NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\\\/\",\"name\":\"IGC Announces Rebranding, Changes Name to IGC Pharma, Inc. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MTEzNSM1NDY5OTEwIzUwMDExMTY0NA==\",\"datePublished\":\"2023-03-20T12:49:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MTEzNSM1NDY5OTEwIzUwMDExMTY0NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MTEzNSM1NDY5OTEwIzUwMDExMTY0NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IGC Announces Rebranding, Changes Name to IGC Pharma, Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IGC Announces Rebranding, Changes Name to IGC Pharma, Inc. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/","og_locale":"en_US","og_type":"article","og_title":"IGC Announces Rebranding, Changes Name to IGC Pharma, Inc. - Market Newsdesk","og_description":"POTOMAC, Md., March 20, 2023 (GLOBE NEWSWIRE) &#8212; India Globalization Capital, Inc. (NYSE American: IGC) (\u201cIGC\u201d or the \u201cCompany\u201d) today announces it will begin operating under the new name IGC Pharma, Inc., (dba IGC) effective March 30, 2023, as part of a rebranding strategy that better reflects IGC Pharma\u2019s strategic focus and vision for the future. Our common stock will continue to be quoted on the NYSE American under the same symbol IGC. Trading of our common stock under our new name will commence on March 31, 2023. Our CUSIP and EIN numbers will remain the same. The name change to IGC Pharma, Inc. acknowledges the Company\u2019s identity as a developer of drug assets for treating diseases, including, but not &hellip; Continue reading \"IGC Announces Rebranding, Changes Name to IGC Pharma, Inc.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-20T12:49:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTEzNSM1NDY5OTEwIzUwMDExMTY0NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IGC Announces Rebranding, Changes Name to IGC Pharma, Inc.","datePublished":"2023-03-20T12:49:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/"},"wordCount":745,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTEzNSM1NDY5OTEwIzUwMDExMTY0NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/","name":"IGC Announces Rebranding, Changes Name to IGC Pharma, Inc. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTEzNSM1NDY5OTEwIzUwMDExMTY0NA==","datePublished":"2023-03-20T12:49:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTEzNSM1NDY5OTEwIzUwMDExMTY0NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTEzNSM1NDY5OTEwIzUwMDExMTY0NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-rebranding-changes-name-to-igc-pharma-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IGC Announces Rebranding, Changes Name to IGC Pharma, Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/741222","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=741222"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/741222\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=741222"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=741222"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=741222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}